Argent BioPharma Limited (ASX:RGT)

Argent BioPharma Revenue

Argent BioPharma had revenue of 171.50K AUD in the half year ending December 31, 2025, a decrease of -71.39%. This brings the company's revenue in the last twelve months to 347.78K, up 17.56% year-over-year. In the fiscal year ending June 30, 2025, Argent BioPharma had annual revenue of 180.57K, down -79.74%.

• Revenue (ttm): 347.78K
• Revenue Growth: +17.56%
• P/S Ratio: 9.75
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 3.39M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	180.57K	-710.52K	-79.74%
Jun 30, 2024	891.08K	-2.50M	-73.70%
Jun 30, 2023	3.39M	-1.34M	-28.41%
Jun 30, 2022	4.73M	1.74M	57.94%
Jun 30, 2021	3.00M	916.88K	44.10%